This inventor holds 2 USPTO granted patents. Top assignee: Hoechst Japan Limited. Active years: 1997.
Location History:
- Fujisawa, JP (1997)
- Kanagawa, JP (1997)
Company Filing History:
Years Active: 1997
Title: Innovations in Osteoporosis Treatment by Hiroyasu Tobe
Introduction
Hiroyasu Tobe is a notable inventor based in Fujisawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of osteoporosis. With a total of 2 patents to his name, Tobe's work focuses on innovative therapeutic agents derived from natural compounds.
Latest Patents
Tobe's latest patents include a pharmaceutical composition for treating osteoporosis that utilizes xanthohumol as an active ingredient. This compound, obtained from hop extracts, exhibits bone resorption inhibiting activity, making it a valuable therapeutic agent for osteoporosis. Another patent involves a composition that comprises humulones, including humulone, cohumulone, and adhumulone, along with iso-alpha acid derivatives. These compounds also demonstrate bone resorption inhibiting properties, further supporting their use in osteoporosis treatment.
Career Highlights
Hiroyasu Tobe is currently associated with Hoechst Japan Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential to improve the quality of life for individuals suffering from osteoporosis.
Collaborations
Tobe has collaborated with notable coworkers, including Kazuyuki Kitamura and Osamu Komiyama, to enhance the scope and impact of his research.
Conclusion
Hiroyasu Tobe's innovative approaches to osteoporosis treatment highlight the importance of natural compounds in pharmaceutical development. His contributions are paving the way for new therapeutic options in the fight against this debilitating condition.